Mayo Clinic Laboratory and Pathology Research Roundup: Feb. 12 - Insights
This week’s Research Roundup highlights the prediction of oncologic outcomes in Renal cell carcinoma after surgery.
A study by Mayo Clinic researchers found that most patients with suspected spinal cord inflammation of unknown cause have an alternative, specific diagnosis. The research is published in Neurology, the medical journal of the American...
Research Roundup Archives - Page 12 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Overcoming Fear of Public Speaking with "The Art of Laughter" - Insights
Nhien Chau, Clinical Laboratory Technologist in the Biochemical Genetics Laboratory at Mayo Clinic, decided to face his fear of public speaking by joining the Rochester Chamber Toastmasters group.
September 2023 - Laboratory Genetics & Genomics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Laboratory Genetics and Genomics.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 20 - Insights
This week’s Research Roundup highlights prehospital transfusion for gastrointestinal bleeding.
CPT Codes and LOINC Update: May 2020 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of May.
A letter of appreciation, which was forwarded to Mayo Clinic President and CEO John Noseworthy, M.D., and Board of Trustees member Samual Di Piazza, Jr., described the outstanding contributions to science and education that Mayo Clinic DLMP...
Plummer Building #ThrowbackThursday - Insights
Opened in 1928, the Plummer Building is an iconic symbol of Mayo Clinic, designated as a National Historic Landmark. It is named for Henry S. Plummer, M.D., the “diversified genius” who designed it and who created many of the systems and...
In an article about "titans who defined a new era in business during the last decade," former Mayo Clinic President and CEO John Noseworthy, M.D., looked back on his tenure with gratitude.